Related Experiment Video
Updated: Jun 1, 2026

08:57
Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
Non-teleological differentiation of malignancy (review)
Oncology Reports
|May 25, 2011
Summary
Tumor cell de-differentiation differs from normal cell retro-differentiation, being a stochastic process with fragmented gene expression. Tumor cells cannot maintain differentiation due to lost regulatory mechanisms and selfish behavior.
Area of Science:
- Cell biology
- Cancer research
- Developmental biology
Background:
- Cellular differentiation is a fundamental process in normal development.
- Malignant tumors exhibit altered cellular characteristics, including apparent de-differentiation.
- The mechanisms and implications of tumor cell de-differentiation are not fully understood.
Purpose of the Study:
- To differentiate the processes of tumor cell de-differentiation and normal cell retro-differentiation.
- To investigate the characteristics of gene expression during tumor cell differentiation.
- To explore the reasons why tumor cells fail to maintain a differentiated state.
Main Methods:
- Comparative analysis of tumor cell de-differentiation and normal cell retro-differentiation.
- Examination of gene expression patterns in differentiating tumor cells.
- Evaluation of the role of microenvironments and regulatory mechanisms in maintaining cell differentiation.
Main Results:
- Tumor cell de-differentiation is a stochastic process, unlike the programmed retro-differentiation of normal cells.
- Tumor cell differentiation is characterized by fragmented gene expression.
- Tumor cells lack the ability to maintain a differentiated state in normal microenvironments due to lost regulatory mechanisms.
- The 'selfish' behavior of tumor cells correlates with a loss of teleology in their differentiation program.
Conclusions:
- Tumor cell de-differentiation and normal cell retro-differentiation are distinct processes.
- The induction of tumor cell differentiation requires different strategies than for normal cells.
- The differentiation program in tumor cells is a remnant of the normal process, lacking teleological purpose and regulatory control.
Related Concept Videos
Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

